Trial intelligence / Profile preview

MOVE-OK: Exercise Incentives and Corticosteroids in Knee Osteoarthritis

NCT05035810Phase 3Active, not recruiting

Sponsor
VA Office of Research & Development
Start
Mar 2022
Primary completion
Nov 2024
Countries
1
01

Overview

A Phase 3 trial of corticosteroids in osteoarthritis (OA), sponsored by VA Office of Research & Development. Started Mar 2022; status: active, not recruiting.

02

Drugs

corticosteroids
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT05035810.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05035810.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call